These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15793554)

  • 21. Infliximab for the treatment of psoriasis: clinical experience at the State University of New York at Buffalo.
    Kalb RE; Gurske J
    J Am Acad Dermatol; 2005 Oct; 53(4):616-22. PubMed ID: 16198781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [How to treat a psoriatic nail?].
    Ann Dermatol Venereol; 1993; 120(3):265-7. PubMed ID: 8239373
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
    Gisondi P; Cotena C; Tessari G; Girolomoni G
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of lesional T cells in recalcitrant psoriasis during infliximab therapy.
    Bovenschen HJ; Van De Kerkhof PC; Gerritsen WJ; Seyger MM
    Eur J Dermatol; 2005; 15(6):454-8. PubMed ID: 16280298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nail psoriasis].
    Gueissaz F; Borradori L; Dubertret L
    Ann Dermatol Venereol; 1992; 119(1):57-63. PubMed ID: 1562156
    [No Abstract]   [Full Text] [Related]  

  • 26. Improvement of anti-TNFα antibody-induced pustular psoriasis by azathioprine.
    Kayama T; Otsuka A; Miyachi Y; Kabashima K
    Eur J Dermatol; 2012; 22(4):565-6. PubMed ID: 22853939
    [No Abstract]   [Full Text] [Related]  

  • 27. [Up-date on the use of infliximab in dermatology. Introduction].
    Sánchez-Carazo J
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():1. PubMed ID: 19080984
    [No Abstract]   [Full Text] [Related]  

  • 28. Topical calcipotriol therapy in nail psoriasis: a study of 24 cases.
    Zakeri M; Valikhani M; Mortazavi H; Barzegari M
    Dermatol Online J; 2005 Dec; 11(3):5. PubMed ID: 16409901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained effects of low dose infliximab in combination with methotrexate in the management of chronic recalcitrant psoriasis.
    Zargari O
    Dermatol Online J; 2005 Dec; 11(3):21. PubMed ID: 16409917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy.
    Markham T; Mathews C; Rogers S; Mullan R; Bresnihan B; Fitzgerald O; Veale DJ; Fearon U
    Br J Dermatol; 2006 Dec; 155(6):1191-6. PubMed ID: 17107388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment.
    Nikas SN; Voulgari PV; Takalou IP; Katsimbri P; Drosos AA
    Ann Rheum Dis; 2005 Nov; 64(11):1665-7. PubMed ID: 16227426
    [No Abstract]   [Full Text] [Related]  

  • 32. Cutaneous granulomas during infliximab therapy for spondyloarthropathy.
    Dubosc AE; Perroud AM; Bagot M; Farenq V; Chevalier X; Maitre B; Claudepierre P
    J Rheumatol; 2008 Jun; 35(6):1222-3. PubMed ID: 18412298
    [No Abstract]   [Full Text] [Related]  

  • 33. Infliximab in recalcitrant generalized pustular arthropatic psoriasis.
    Vieira Serrão V; Martins A; Lopes MJ
    Eur J Dermatol; 2008; 18(1):71-3. PubMed ID: 18086593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of infliximab in Cogan's syndrome.
    Ghadban R; Couret M; Zenone T
    J Rheumatol; 2008 Dec; 35(12):2456-8. PubMed ID: 19040322
    [No Abstract]   [Full Text] [Related]  

  • 35. Gastric MALT lymphoma in a patient receiving infliximab for psoriasis.
    Girard C; Guillot B; Bessis D
    Br J Dermatol; 2008 Aug; 159(2):497-8. PubMed ID: 18547313
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of nail psoriasis with efalizumab: a preliminary study.
    Lamerson C; Stevens G; Sax K
    Cutis; 2008 Sep; 82(3):217-20. PubMed ID: 18856162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
    Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
    J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review and expert opinion on prevention and treatment of infliximab-related infusion reactions.
    Lecluse LL; Piskin G; Mekkes JR; Bos JD; de Rie MA
    Br J Dermatol; 2008 Sep; 159(3):527-36. PubMed ID: 18627374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of ustekinumab in sub-erythrodermic psoriasis: when TNF-blockers fail.
    Buggiani G; D'Erme AM; Krysenka A; Pescitelli L; Lotti T; Prignano F
    Dermatol Ther; 2012; 25(3):283-5. PubMed ID: 22913449
    [No Abstract]   [Full Text] [Related]  

  • 40. Using 'number needed to treat' to express the magnitudes of benefit of ultraviolet B phototherapy and of antitumour necrosis factor-alpha therapies for psoriasis.
    Dawe RS
    Br J Dermatol; 2010 Feb; 162(2):456-7. PubMed ID: 19919632
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.